PI
CORV

Putnam Investments’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Putnam Investments’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,654,439
Closed -$5.31M – 963
2019
Q3 		$5.31M Buy
2,654,439
+1,333,333
+101% +$2.7M 0.01% 486
2019
Q2 		$2.85M Sell
1,321,106
-79,427
-6% -$203K 0.01% 667
2019
Q1 		$4.43M Sell
1,400,533
-1,691,600
-55% -$5.47M 0.01% 541
2018
Q4 		$7.7M Hold
3,092,133
– – 0.02% 372
2018
Q3 		$12.4M Hold
3,092,133
– – 0.03% 345
2018
Q2 		$11.7M Hold
3,092,133
– – 0.03% 345
2018
Q1 		$7.17M Hold
3,092,133
– – 0.02% 436
2017
Q4 		$4.79M Hold
3,092,133
– – 0.01% 529
2017
Q3 		$6.62M Sell
3,092,133
-1,306,742
-30% -$4.45M 0.02% 457
2017
Q2 		$19.9M Buy
4,398,875
+960,391
+28% +$3.48M 0.05% 260
2017
Q1 		$10.3M Sell
3,438,484
-70,504
-2% -$208K 0.02% 384
2016
Q4 		$9.69M Sell
3,508,988
-164,634
-4% -$471K 0.02% 384
2016
Q3 		$11.5M Buy
3,673,622
+797,523
+28% +$2.91M 0.03% 357
2016
Q2 		$14.8M Sell
2,876,099
-66,028
-2% -$317K 0.04% 343
2016
Q1 		$12M Sell
2,942,127
-7,215
-0.2% -$38.6K 0.03% 400
2015
Q4 		$23.9M Buy
2,949,342
+148,606
+5% +$1.24M 0.05% 282
2015
Q3 		$23.6M Buy
2,800,736
+964,836
+53% +$8.89M 0.05% 279
2015
Q2 		$17.3M Buy
1,835,900
+435,066
+31% +$4.05M 0.03% 358
2015
Q1 		$13M Buy
1,400,834
+190,191
+16% +$1.82M 0.03% 429
2014
Q4 		$11.2M Buy
1,210,643
+287,362
+31% +$2.42M 0.02% 472
2014
Q3 		$8.24M Buy
+923,281
New +$6.72M 0.02% 551

Other funds holding CORV

TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Putnam Investments's CORV Position: Q4 2019 in Review

Putnam Investments sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q4 2019, closing a stake of 2,654,439 shares — an estimated $5.31M sold.

Putnam Investments first reported a position in CORV in Q3 2014 and held it in 21 quarters. The position peaked at $23.9M in Q4 2015. 31 funds tracked by Wall St. Rank hold CORV as of Q4 2019.

  • Putnam Investments reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q4 2019 after selling out during the quarter.
  • Putnam Investments sold 2,654,439 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q4 2019, an estimated $5.31M.
  • Putnam Investments first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q3 2014 and held it in 21 quarters.
  • Putnam Investments's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $23.9M in Q4 2015.
  • 31 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2019.

Based on Putnam Investments's 13F filing for Q4 2019, filed 14 Feb 2020.